Primary |
Hypercholesterolaemia |
22.3% |
Hyperlipidaemia |
16.8% |
Blood Cholesterol Increased |
10.6% |
Hypertension |
9.5% |
Dyslipidaemia |
7.3% |
Supplementation Therapy |
6.7% |
Diabetes Mellitus |
6.1% |
Blood Cholesterol |
2.8% |
Cardiac Disorder |
2.8% |
Gastrointestinal Disorder |
1.7% |
Hypertriglyceridaemia |
1.7% |
Influenza Immunisation |
1.7% |
Low Density Lipoprotein Increased |
1.7% |
Renal Transplant |
1.7% |
Anticoagulant Therapy |
1.1% |
Arthralgia |
1.1% |
Benign Prostatic Hyperplasia |
1.1% |
Blood Glucose Decreased |
1.1% |
Blood Homocysteine Increased |
1.1% |
Blood Pressure Decreased |
1.1% |
|
Death |
16.5% |
Rhabdomyolysis |
9.4% |
Vomiting |
9.4% |
Malaise |
5.9% |
Apparent Death |
4.7% |
Muscle Spasms |
4.7% |
Nausea |
4.7% |
Percutaneous Coronary Intervention |
4.7% |
Thrombocytopenia |
4.7% |
Blood Glucose Increased |
3.5% |
Blood Pressure Increased |
3.5% |
Cerebrovascular Accident |
3.5% |
Gamma-glutamyltransferase Increased |
3.5% |
Pain In Extremity |
3.5% |
Suicidal Behaviour |
3.5% |
Trismus |
3.5% |
Weight Decreased |
3.5% |
Amnesia |
2.4% |
Angina Pectoris |
2.4% |
Arrhythmia |
2.4% |
|
Secondary |
Hypertension |
19.7% |
Drug Use For Unknown Indication |
14.1% |
Rheumatoid Arthritis |
12.7% |
Blood Cholesterol Increased |
11.3% |
Hypercholesterolaemia |
9.9% |
Renal Transplant |
6.3% |
Constipation |
3.5% |
Low Density Lipoprotein Increased |
3.5% |
Blood Triglycerides |
2.8% |
Diabetes Mellitus |
2.1% |
Diuretic Therapy |
2.1% |
Dyspepsia |
2.1% |
Hyperlipidaemia |
2.1% |
Blood Homocysteine Increased |
1.4% |
Cerebrovascular Accident |
1.4% |
Gastrointestinal Disorder |
1.4% |
Neuropathy Peripheral |
1.4% |
Arteriosclerosis |
0.7% |
Blood Triglycerides Increased |
0.7% |
Colitis |
0.7% |
|
Liver Function Test Abnormal |
14.0% |
Urinary Tract Infection |
9.3% |
Vomiting |
9.3% |
Liver Injury |
7.0% |
Rhabdomyolysis |
7.0% |
Suicidal Behaviour |
7.0% |
Death |
4.7% |
Mitral Valve Prolapse |
4.7% |
Pain In Extremity |
4.7% |
Renal Failure |
4.7% |
Swollen Tongue |
4.7% |
Upper Respiratory Tract Infection |
4.7% |
Arthritis |
2.3% |
Blood Pressure Increased |
2.3% |
Cardiac Arrest |
2.3% |
Cardiac Failure |
2.3% |
Cholelithiasis |
2.3% |
Depression |
2.3% |
Diabetes Mellitus |
2.3% |
Drug Hypersensitivity |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
12.3% |
Hypertension |
11.9% |
Drug Use For Unknown Indication |
9.3% |
Osteoporosis |
8.6% |
Depression |
6.1% |
Psoriasis |
4.8% |
Anxiety |
4.6% |
Hyperlipidaemia |
4.6% |
Type 2 Diabetes Mellitus |
4.6% |
Diabetes Mellitus |
4.0% |
Hypercholesterolaemia |
3.5% |
Blood Cholesterol |
3.3% |
Blood Cholesterol Increased |
3.3% |
Atrial Fibrillation |
2.8% |
Dyspepsia |
2.8% |
Gastrooesophageal Reflux Disease |
2.8% |
Psoriatic Arthropathy |
2.8% |
Renal Transplant |
2.6% |
Restless Legs Syndrome |
2.6% |
Pain |
2.5% |
|
Weight Decreased |
13.5% |
Vomiting |
9.4% |
Viral Infection |
7.3% |
Type 2 Diabetes Mellitus |
6.3% |
Vitreous Haemorrhage |
6.3% |
Death |
5.2% |
Acute Myocardial Infarction |
4.2% |
Diabetes Mellitus |
4.2% |
Drug Ineffective |
4.2% |
Dyspnoea |
4.2% |
Nausea |
4.2% |
Suicidal Ideation |
4.2% |
Tremor |
4.2% |
White Blood Cell Count Decreased |
4.2% |
Aplasia Pure Red Cell |
3.1% |
Headache |
3.1% |
Pruritus |
3.1% |
Renal Failure Chronic |
3.1% |
Septic Shock |
3.1% |
Thrombocytopenia |
3.1% |
|
Interacting |
Hypertension |
20.0% |
Immunosuppression |
20.0% |
Hyperlipidaemia |
13.3% |
Dyspepsia |
6.7% |
Hyperuricaemia |
6.7% |
Hypogonadism |
6.7% |
Hypothyroidism |
6.7% |
Osteoporosis |
6.7% |
Product Used For Unknown Indication |
6.7% |
Thrombosis Prophylaxis |
6.7% |
|
Aspartate Aminotransferase Increased |
100.0% |
|